These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23016837)

  • 41. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.
    Mortby ME; Burns R; Eramudugolla R; Ismail Z; Anstey KJ
    J Alzheimers Dis; 2017; 59(1):141-153. PubMed ID: 28598846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
    Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
    JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.
    Peters ME; Rosenberg PB; Steinberg M; Norton MC; Welsh-Bohmer KA; Hayden KM; Breitner J; Tschanz JT; Lyketsos CG;
    Am J Geriatr Psychiatry; 2013 Nov; 21(11):1116-24. PubMed ID: 23567370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.
    Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T
    J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive Decline in Patients with Leukoaraiosis Within 5 Years after Initial Stroke.
    Kumral E; Güllüoğlu H; Alakbarova N; Deveci EE; Çolak AY; Çağında AD; Evyapan D; Orman M
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2338-47. PubMed ID: 26236001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.
    Taragano FE; Allegri RF; Heisecke SL; Martelli MI; Feldman ML; Sánchez V; García VA; Tufro G; Castro DM; Leguizamón PP; Guelar V; Ruotolo E; Zegarra C; Dillon C
    J Alzheimers Dis; 2018; 62(1):227-238. PubMed ID: 29439333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.
    Valero S; Marquié M; De Rojas I; Espinosa A; Moreno-Grau S; Orellana A; Montrreal L; Hernández I; Mauleón A; Rosende-Roca M; Alegret M; Pérez-Cordón A; Ortega G; Roberto N; Sanabria A; Abdelnour C; Gil S; Tartari JP; Vargas L; Esteban-De Antonio E; Benaque A; Tárraga L; Boada M; Ruíz A
    Sci Rep; 2020 Nov; 10(1):20058. PubMed ID: 33208795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.
    Ye BS; Jang EY; Kim SY; Kim EJ; Park SA; Lee Y; Hong CH; Choi SH; Yoon B; Yoon SJ; Na HR; Lee JH; Jeong JH; Kim HJ; Na DL; Seo SW
    J Alzheimers Dis; 2016; 49(2):483-91. PubMed ID: 26484923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
    Pilotto A; Gazzina S; Benussi A; Manes M; Dell'Era V; Cristillo V; Cosseddu M; Turrone R; Alberici A; Padovani A; Borroni B
    Neurodegener Dis; 2017; 17(6):286-291. PubMed ID: 28881351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment.
    Spalletta G; Girardi P; Caltagirone C; Orfei MD
    J Alzheimers Dis; 2012; 29(4):761-72. PubMed ID: 22349686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.
    Brodaty H; Heffernan M; Kochan NA; Draper B; Trollor JN; Reppermund S; Slavin MJ; Sachdev PS
    Alzheimers Dement; 2013 May; 9(3):310-317.e1. PubMed ID: 23110866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in Remission.
    Fischer CE; Kortebi I; Karameh WK; Kumar S; Gallagher D; Golas A; Munoz D; Barfett J; Butters MA; Bowie CR; Flint A; Rajji T; Herrmann N; Pollock BG; Mulsant B; Schweizer TA; Mah L;
    J Alzheimers Dis; 2019; 67(4):1305-1311. PubMed ID: 30741676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study.
    Rozum WJ; Cooley B; Vernon E; Matyi J; Tschanz JT
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):1087-1094. PubMed ID: 30945374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does semantic memory impairment in amnestic MCI with hippocampal atrophy conform to a distinctive pattern of progression?
    Quaranta D; Vita MG; Spinelli P; Scaricamazza E; Castelli D; Lacidogna G; Piccininni C; Rossini PM; Gainotti G; Marra C
    Curr Alzheimer Res; 2014 May; 11(4):399-407. PubMed ID: 24635841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis.
    Roberto N; Portella MJ; Marquié M; Alegret M; Hernández I; Mauleón A; Rosende-Roca M; Abdelnour C; de Antonio EE; Gil S; Tartari JP; Vargas L; Espinosa A; Ortega G; Pérez-Cordón A; Sanabria Á; Orellana A; de Rojas I; Moreno-Grau S; Montrreal L; Alarcón-Martín E; Ruíz A; Tárraga L; Boada M; Valero S
    Sci Rep; 2021 Mar; 11(1):6448. PubMed ID: 33742011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subtype of mild cognitive impairment and progression to dementia and death.
    Yaffe K; Petersen RC; Lindquist K; Kramer J; Miller B
    Dement Geriatr Cogn Disord; 2006; 22(4):312-9. PubMed ID: 16940725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory - Clinician rating scale (NPI-C).
    Zaidi S; Kat MG; de Jonghe JF
    Int Psychogeriatr; 2014 Jul; 26(7):1139-45. PubMed ID: 24622334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging.
    Krell-Roesch J; Syrjanen JA; Machulda MM; Christianson TJ; Kremers WK; Mielke MM; Knopman DS; Petersen RC; Vassilaki M; Geda YE
    Int J Geriatr Psychiatry; 2021 Sep; 36(9):1362-1369. PubMed ID: 33724517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.